DTx Pharma Raises $100 Million Round
Wednesday, March 17, 2021
Photo courtesy of DTx Pharma. In May 2020, the biotech expanded its footprint into a new 14,000 square foot lab and office space in Sorrento Valley.
San Diego-based DTx Pharma, a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, has raised a $100 million in Series B financing...